This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Synapses of the reward system at stake in ... Autism spectrum disorders are a heterogeneous group of ... (07 Aug 2018)
  A diverse diet may not be the healthiest ... Encouraging people to eat a wide variety of foods to ensure they ... (07 Aug 2018)
Older adults who get physical can lower ... Adults in their early 60s, who spend less time sitting and more ... (07 Aug 2018)
People who sleep for more than eight hours ... A large study led by Keele University has found that sleeping ... (07 Aug 2018)
Learning while sleeping? Our learning ... A group of researchers found that our learning capabilities are ... (07 Aug 2018)
Monday, 14 May 2018 20:18

Osteoporosis Drug May Benefit Heart Health Featured

Rate this item
(0 votes)

The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack, and stroke in a Journal of Bone and Mineral Research study of patients with hip fractures. The association was seen for up to 10 years after fracture.

In the study, patients newly diagnosed with hip fracture from 2005 through 2013 were followed until late 2016. Among 34,991 patients, 4602 (13%) received osteoporosis treatment during follow-up.

Alendronate was associated with 67% and 45% lower risks of one-year cardiovascular death and heart attack, respectively. It was associated with an 18% reduced risk of stroke within five years and a 17% reduced risk of stroke within 10 years. Protective effects were not evident for other classes of osteoporosis treatments.

“It is well established that there is a world-wide crisis in the treatment of osteoporosis, due to patients’ awareness of the extremely rare side effects,” said senior author Dr. Ching-Lung Cheung, of the University of Hong Kong. “Our findings show that alendronate is potentially cardioprotective in hip fracture patients. Therefore, physicians should consider prescribing alendronate or other nitrogen-containing bisphosphonates to hip fracture patients soon after their fracture, and patients should also have good compliance with alendronate treatment, as this is not only good for your bones, but also your heart.”

In addition to clinical management, the study also has important implications in clinical trial design of anti-osteoporosis medications. The US Food and Drug Administration recently requested more data before reaching a decision on whether to approve the osteoporosis drug romosozumab, due to excess cardiovascular adverse events in the romosozumab arm compared with the alendronate arm. “In light of these important deliberations, our results suggest that such differences in cardiovascular adverse events could be potentially related to a protective association of alendronate, rather than an increase in cardiovascular adverse events related to romosozumab use, said Dr. Cheung.”


Source: Wiley
Full bibliographic information

Chor-Wing Sing, Angel YS Wong, Douglas P Kiel, Elaine YN Cheung, Joanne KY Lam, Tommy T Cheung, Esther W Chan, Annie WC Kung, Ian CK Wong and Ching-Lung Cheung. Association of Alendronate and Risk of Cardiovascular Events in Patients With Hip Fracture. Journal of Bone and Mineral Research. DOI: 10.1002/jbmr.3448. 

Read 220 times Last modified on Tuesday, 15 May 2018 18:30

TheSynapse Videos

0
0
0
0
0
0

Latest news

Highlights

  • Interactive Discussion on Valsartan

     

     

    The Malta Medicines Authority in collaboration with the Superintendence
    of Public Health and the Department of Pharmacy University of Malta
    would like to cordially invite you to an interactive scientific discussion:

     

     


    THE VALSARTAN SAGA


    SCIENCE | MYTHS | REALITIES

     


    led by Professor Anthony Serracino Inglott

     


    Date: Wednesday 25 July 2018

     


    Time: 20:00
    Venue: Conference Room, Life Sciences Park, San Ġwann

     


    Refreshments will be served


    RSVP: info.medicinesauthority@gov.mt | 23439202

    Written on July 21, 2018
  • Les Laboratoires Servier - Job Vacancy
    Written on June 29, 2018 Read more...

Join

Connect with other Medical Professionals on fb in a closed facebook group

captcha  

Login

Template Settings

Theme Colors

Cyan Red Green Oranges Teal

Layout

Wide Boxed Framed Rounded
Patterns for Layour: Boxed, Framed, Rounded
Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…